about
Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasisBone marrow suppression and severe anaemia associated with persistent Plasmodium falciparum infection in African children with microscopically undetectable parasitaemiaIn vivo expression of neuroglobin in reactive astrocytes during neuropathology in murine models of traumatic brain injury, cerebral malaria, and autoimmune encephalitisPlasmodium berghei ANKA: erythropoietin activates neural stem cells in an experimental cerebral malaria modelGlucagon-like peptide-1 analogue, liraglutide, in experimental cerebral malaria: implications for the role of oxidative stress in cerebral malariaGLP-1 improves neuropathology after murine cold lesion brain traumaEffects of the vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor SU5416 on in vitro cultures of Plasmodium falciparum.Geographical and temporal conservation of antibody recognition of Plasmodium falciparum variant surface antigens.Reproductive tract infections in women seeking abortion in Vietnam.Amodiaquine-associated adverse effects after inadvertent overdose and after a standard therapeutic dose.Parents' perceptions, attitudes and acceptability of treatment of childhood malaria with artemisinin combination therapies in ghana.Systemic and Cerebral Vascular Endothelial Growth Factor Levels Increase in Murine Cerebral Malaria along with Increased Calpain and Caspase Activity and Can be Reduced by Erythropoietin Treatment.Endothelial glycocalyx on brain endothelial cells is lost in experimental cerebral malariaLevels of antibody to conserved parts of Plasmodium falciparum merozoite surface protein 1 in Ghanaian children are not associated with protection from clinical malaria.Antibodies to variant antigens on the surfaces of infected erythrocytes are associated with protection from malaria in Ghanaian children.Retinopathy in severe malaria in Ghanaian children--overlap between fundus changes in cerebral and non-cerebral malaria.Brain mitochondrial function in a murine model of cerebral malaria and the therapeutic effects of rhEPO.Human genetic polymorphisms in the Knops blood group are not associated with a protective advantage against Plasmodium falciparum malaria in Southern Ghana.Subconjunctival Dirofilaria repens Infestation: A Light and Scanning Electron Microscopy Study.Differential microRNA expression in experimental cerebral and noncerebral malaria.Epidemiological study of the association between malaria and helminth infections in NigeriaCNS hypoxia is more pronounced in murine cerebral than noncerebral malaria and is reversed by erythropoietinPolymorphisms in the Haem Oxygenase-1 promoter are not associated with severity of Plasmodium falciparum malaria in Ghanaian children.Molecular Detection of the Carriage Rate of Four Intestinal Protozoa with Real-Time Polymerase Chain Reaction: Possible Overdiagnosis of Entamoeba histolytica in NigeriaInsights into deregulated TNF and IL-10 production in malaria: implications for understanding severe malarial anaemia.Erythropoietin treatment alleviates ultrastructural myelin changes induced by murine cerebral malaria.Recombinant human erythropoietin increases survival and reduces neuronal apoptosis in a murine model of cerebral malaria.Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine.Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up.Antibody responses to Rhoptry-Associated Protein-1 (RAP-1) of Plasmodium falciparum parasites in humans from areas of different malaria endemicity.Effect of concomitant artesunate administration and cytochrome P4502C8 polymorphisms on the pharmacokinetics of amodiaquine in Ghanaian children with uncomplicated malaria.Outbreak of pneumocystis pneumonia in renal and liver transplant patients caused by genotypically distinct strains of Pneumocystis jiroveciiAntibodies to the N-terminal block 2 of Plasmodium falciparum merozoite surface protein 1 are associated with protection against clinical malaria.Progressive disseminated histoplasmosis in the HIV population in Europe in the HAART era. Case report and literature review.Endothelial Glycocalyx: Shedding Light on Malaria Pathogenesis.A randomized trial of artesunate-amodiaquine versus artemether-lumefantrine in Ghanaian paediatric sickle cell and non-sickle cell disease patients with acute uncomplicated malaria.Population Pharmacokinetic Characteristics of Amikacin in Suspected Cases of Neonatal Sepsis in a Low-Resource African Setting: A Prospective Nonrandomized Single-Site Study.Absence of Pneumocystis jirovecii Colonization in Human Immunodeficiency Virus-Infected Individuals With and Without Airway Obstruction and With Undetectable Viral LoadFactors contributing to the development of anaemia in Plasmodium falciparum malaria: what about drug-resistant parasites?Pretreatment blood concentrations of chloroquine in patients with malaria infection: relation to response to treatment.
P50
Q24633365-F1759ABF-89D3-4E33-BB2A-71B592BB9F39Q24812638-06D83BC4-991A-4EB8-AAB0-410B4FD0BF3EQ28285116-02FDD552-F786-4DBB-A5DC-03D072DC6D26Q28297478-DF4B6BFF-9150-41BB-A86A-C46D0AAE4E8BQ28597322-3520EEE1-E12E-47BA-AD2B-5AF59A2A55A5Q28651569-8AD85315-2636-4E54-987B-8CE30A80B43AQ30579979-9E03B6F9-0C8D-487B-BDE4-24E8D38A41EDQ31064176-D24E3A24-7EFC-48A1-AB9A-73D955DB191CQ33403881-C08D5702-A238-4B6D-8F52-11B19B0E6ABEQ33605669-BBB9D68B-C088-4E44-8DA0-417E4A1AF23DQ33605684-DE85E401-CD54-46D3-8C6C-95815FF21EB9Q33775828-A6D082CA-115D-40A3-86E6-BB4F3D7210FDQ33851512-23A5D228-6E47-46EC-BD87-B978C2EF8B84Q33866742-BFC1286F-E575-4CDC-949C-9709A42D4CC5Q34007707-AB3F6FD8-0B8B-45E8-84F3-F7B3AF986219Q34081862-A939C9BB-7BD8-4890-A460-5791A7B41D30Q34383686-E405A5A2-00B8-4D0F-80CB-BD22DF72FD28Q34481349-E691BB36-3C37-4526-B6E2-F90393372E64Q35015118-6087C58C-B427-4C5C-8548-CBE576789EEFQ35075787-491E86CE-B2F9-4683-9D3F-3984F77EF854Q35150317-E43685CF-5C70-41EF-AAE1-CC6F93DCF2B6Q35235711-C377B35A-7A70-41DF-9666-0984D5081B1EQ35404337-91755917-9DCA-4BC9-9ADD-9049E62505C7Q35933892-D4342791-2155-44B6-9B29-AC98BBB52C9CQ36311915-29411309-FBD2-4738-B076-3067E727975FQ36411555-497DEBFD-8971-4573-90A8-B5C713095763Q36481623-FC6C39F1-2F78-4FEB-99AE-23804134DE5EQ36507484-496CD6E8-CC7D-4AC2-9A1B-CE64CCAE652AQ36782415-F722E3FC-737C-4FC2-B429-DB0AF67CEFDBQ36888215-40BF3CB1-1D0E-4C1F-9320-DE8D005EFF2BQ36993430-45CB3C5C-A95D-4D5F-B37A-6DD86AAA4E82Q37305589-27722A4A-CEF6-45CB-8679-38E0B950DAB3Q37582802-4E9ED29A-70F6-4F36-BF19-6214BF315682Q38195802-E1DEDAEF-F9B0-44A1-9795-C1615AA840B3Q38830476-1506D9B3-8546-44CA-A1A8-2E8259714B14Q38861043-7096FC3A-42FF-4A23-8FAD-947426DF1D5AQ38873556-6D7CFC1C-FCE7-4C7A-98F3-43711396BF83Q39242862-949EF689-69A6-4999-A6A9-22509C72B07BQ39374515-AAC71DCD-EFB5-4C24-82A9-E433A27BE531Q39374523-FAA0113B-9EB6-4251-960F-3C72DC0FEC25
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Jørgen A. Kurtzhals
@nl
Jørgen A. Kurtzhals
@sl
Jørgen Anders Lindholm Kurtzhals
@da
Jørgen Anders Lindholm Kurtzhals
@de
Jørgen Anders Lindholm Kurtzhals
@en
Jørgen Anders Lindholm Kurtzhals
@es
Jørgen Anders Lindholm Kurtzhals
@fo
Jørgen Anders Lindholm Kurtzhals
@fr
Jørgen Anders Lindholm Kurtzhals
@is
Jørgen Anders Lindholm Kurtzhals
@kl
type
label
Jørgen A. Kurtzhals
@nl
Jørgen A. Kurtzhals
@sl
Jørgen Anders Lindholm Kurtzhals
@da
Jørgen Anders Lindholm Kurtzhals
@de
Jørgen Anders Lindholm Kurtzhals
@en
Jørgen Anders Lindholm Kurtzhals
@es
Jørgen Anders Lindholm Kurtzhals
@fo
Jørgen Anders Lindholm Kurtzhals
@fr
Jørgen Anders Lindholm Kurtzhals
@is
Jørgen Anders Lindholm Kurtzhals
@kl
altLabel
Jørgen A L Kurtzhals
@da
Jørgen A L Kurtzhals
@de
Jørgen A L Kurtzhals
@en
Jørgen A. Kurtzhals
@da
Jørgen A. Kurtzhals
@de
Jørgen A. Kurtzhals
@en
Jørgen Kurtzhals
@da
Jørgen Kurtzhals
@de
Jørgen Kurtzhals
@en
prefLabel
Jørgen A. Kurtzhals
@nl
Jørgen A. Kurtzhals
@sl
Jørgen Anders Lindholm Kurtzhals
@da
Jørgen Anders Lindholm Kurtzhals
@de
Jørgen Anders Lindholm Kurtzhals
@en
Jørgen Anders Lindholm Kurtzhals
@es
Jørgen Anders Lindholm Kurtzhals
@fo
Jørgen Anders Lindholm Kurtzhals
@fr
Jørgen Anders Lindholm Kurtzhals
@is
Jørgen Anders Lindholm Kurtzhals
@kl
P106
P1153
10238852300
P21
P31
P496
0000-0003-2760-8713